Edgar Filing: DAVITA HEALTHCARE PARTNERS INC.

DAVITA HEALTHCARE PARTNERS INC.

Date: November 18, 2015

/s/ James K. Hilger

James K. Hilger

Interim Chief Financial Officer and

Chief Accounting Officer

8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): November 10, 2015

DAVITA HEALTHCARE PARTNERS INC.

(Exact name of registrant as specified in its charter)

Delaware

1-14106

No. 51-0354549

(State or other jurisdiction

of incorporation)

(Commission
File Number)

(IRS Employer

Identification No.)

2000 16^th Street

Denver, CO 80202

(Address of principal executive offices including Zip Code)

(303) 405-2100

(Registrant’s telephone number, including area code)

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01.

Other Events.

On November 10, 2015, RMS Lifeline, Inc., a wholly owned subsidiary of DaVita HealthCare Partners Inc. (the “Company”) that operates under the name “Lifeline Vascular Access^SM” (“Lifeline”), received a Civil Investigative Demand (the “CID”) from the U.S. Department of Justice (the “DOJ”). The CID relates to two vascular access centers in Florida that are part of Lifeline’s vascular access business. The CID covers the period from January 1, 2008 through the present.

Based on the language of the CID, the DOJ is conducting a False Claims Act investigation and appears to be reviewing the medical necessity of angiograms performed at the two centers. The CID seeks, among other documents, medical records for 10 patients. Lifeline does not perform dialysis services but instead provides vascular access management services for dialysis patients.

The Company maintains policies and procedures to promote compliance with the False Claims Act and other applicable laws and regulations, and intends to cooperate with the government. The Company cannot predict, however, when this investigation will be resolved, its eventual outcome or scope, or its potential impact on the Company.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.